5-(N-Ethyl-N-Isopropyl)Amiloride

5-(N-Ethyl-N-Isopropyl)Amiloride

SCHEMBL29404178

CCN(c1nc(N)c(C(=O)N=C(N)N)nc1Cl)C(C)C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A5 Q14940 6/20 1.00
CYP1A2 P05177 5/20 1.00
TSHR P16473 4/20 1.00
SLC9A1 P19634 4/20 1.00
CYP2D6 P10635 3/20 1.00
MEN1 O00255 2/20 1.00
GMNN O75496 2/20 1.00
THPO P40225 2/20 1.00
PMP22 Q01453 2/20 1.00
KMT2A Q03164 2/20 1.00
OPRM1 P35372 2/20 1.00
OPRD1 P41143 1/20 1.00
HTR5A P47898 1/20 1.00
PAX8 Q06710 1/20 1.00
PLAU P00749 10/20 0.98
CYP2C19 P33261 2/20 0.67
BLM P54132 2/20 0.67
TDP1 Q9NUW8 2/20 0.67
TP53 P04637 1/20 0.67
NPSR1 Q6W5P4 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
5-(N-Ethyl-N-Isopropyl)Amiloride SCHEMBL9852524 1.00 SLC9A5 (1.00) SLC9A5CYP1A2TSHRSLC9A1CYP2D6
SCHEMBL14504168 0.84 CYP1A2 (0.77) SLC9A5CYP1A2TSHRSLC9A1CYP2D6
SCHEMBL14513859 0.83 SLC9A5 (0.77) SLC9A5CYP1A2TSHRSLC9A1CYP2D6
5-(N-Methyl-N-Isobutyl)Amiloride SCHEMBL9852472 0.80 CYP1A2 (1.00) SLC9A5CYP1A2TSHRSLC9A1CYP2D6
5-(N-Methyl-N-Isobutyl)Amiloride SCHEMBL29404271 0.80 CYP1A2 (1.00) SLC9A5CYP1A2TSHRSLC9A1CYP2D6
SCHEMBL9852481 0.80 CYP1A2 (1.00) SLC9A5CYP1A2TSHRSLC9A1CYP2D6
SCHEMBL29406659 0.80 CYP1A2 (1.00) SLC9A5CYP1A2TSHRSLC9A1CYP2D6
SCHEMBL14513862 0.80 CYP1A2 (0.69) SLC9A5CYP1A2TSHRSLC9A1CYP2D6
5-(N-Ethyl-N-Isopropyl)Amiloride SCHEMBL23663987 0.78 CYP1A2 (0.64) SLC9A5CYP1A2TSHRSLC9A1CYP2D6
5-(N-Ethyl-N-Isopropyl)Amiloride SCHEMBL29375391 0.78 CYP1A2 (0.64) SLC9A5CYP1A2TSHRSLC9A1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119633554-A Smoke carbon dioxide capturing and regenerating system based on bi-component secondary amine 中冶京诚工程技术有限公司 2025-03-18 CN disclosed
CN-119367546-A Composition for enhancing glioma chemotherapeutic drug sensitivity and application thereof 中国人民武装警察部队重庆市总队医院 2025-01-28 CN disclosed
CN-115005772-B Plaque detection method and device based on OCT image and terminal equipment 深圳市中科微光医疗器械技术有限公司 2025-01-24 CN disclosed
CN-119265101-A Method for repairing damaged islet beta cells, product and application 南京师范大学 2025-01-07 CN disclosed
CN-116942669-B Application of amiloride in preparation of medicine for preventing and treating mandarin rhabdovirus infection 中国水产科学研究院珠江水产研究所 2024-02-23 CN disclosed
CN-116942669-A Application of amiloride in preparation of medicine for preventing and treating mandarin rhabdovirus infection 中国水产科学研究院珠江水产研究所 2023-10-27 CN disclosed
EP-4203930-A1 NHE-1 INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS Fondation EspeRare (CH) 2023-07-05 EP disclosed
CN-115005772-A Plaque detection method and device based on OCT image and terminal equipment 深圳市中科微光医疗器械技术有限公司 2022-09-06 CN disclosed
WO-2022125673-A1 CELL-PENETRATING PEPTIDES AND PEPTIDE COMPLEXES AND METHODS OF USE FRED HUTCHINSON CANCER RESEARCH CENTER (US) 2022-06-16 WO disclosed
WO-2022043343-A1 NHE-1 INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS FONDATION ESPERARE (CH) 2022-03-03 WO disclosed
EP-3960165-A1 NHE-1 INHIBITORS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS Fondation EspeRare (CH) 2022-03-02 EP disclosed